Metraipolis › archive › dc_85eefc51e348

Targeted therapy in patients with genetic tumor syndromes — Europe PMC PMID:41210226

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41210226
DOI
10.1515/medgen-2025-2045
License (as archived)
solo-consultazione
Archived
2026-11-08T17:27:11.761Z
SHA-256 of the archived text
ce56e849e0fae72181fdc251e29797f7a084d9e6ec05e20449b347643528c3e5
Stable URL of this page
https://metraipolis.com/documento/dc_85eefc51e348

How to cite

Targeted therapy in patients with genetic tumor syndromes — Europe PMC PMID:41210226 — Europe PMC (en), https://europepmc.org/article/MED/41210226 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85eefc51e348 (Metraipolis archive dc_85eefc51e348, sha256 ce56e849e0fae72181fdc251e29797f7a084d9e6ec05e20449b347643528c3e5)
BibTeX
@misc{dc85eefc51e348,
  title = {Targeted therapy in patients with genetic tumor syndromes — Europe PMC PMID:41210226},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41210226},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85eefc51e348; sha256 ce56e849e0fae72181fdc251e29797f7a084d9e6ec05e20449b347643528c3e5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41210226. Agents can read the archived copy with the MCP tool read_document.